Olsalazine (Standard)

Overview

Olsalazine (Standard) is an orally active prodrug of 5-ASA ( HY-15027 ). Olsalazine (Standard) can inhibit cells proliferation and induce apoptosis . Olsalazine (Standard) can reduce DAI and MPO activity and inhibit inflammatory cytokines levels. Olsalazine (Standard) can be used for the researches of cancer , inflammation and metabolic disease , such as colorectal cancer , inflammatory bowel disease (IBD) and hyperuricemic.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-B0174AR
• CAS No.: 15722-48-2
• Molecular Formula: C14H10N2O6
• Molecular Weight: 302.24
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source